Between 15% and 20% of U.S. adults over the age of 65 have obstructive sleep apnea (OSA), according to research in the ...
VGM Group’s acquisition of mask-fitting platform SleepGlad rounds out the company’s respiratory offering and better aligns it ...
Carbon dioxide (CO2) is a major respiratory metabolite, and continuous monitoring of CO2 concentration in exhaled breath is ...
Smart beds with adjustable head positioning, like Tempur-pedic's Tempur-Ergo smart power base and the Eight Sleep Pod 4 Ultra ...
The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, reaching US$ 878.9 Million in 2024 and an impressive US$ 1,5 ...
ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth ...
An implant for sleep apnea is one of the few CPAP alternatives. This article compares hypoglossal nerve stimulation and ...
Sleep apnea affects over 29 million Americans, with Obstructive Sleep Apnea (characterized by pauses in breathing during ...
While Continuous Positive Airway Pressure (CPAP) machines have long been the standard treatment, many patients find them uncomfortable or difficult to use. Fortunately, Sleep Solution Centers, a ...
Obstructive sleep apnea is caused ... Continuous positive airway pressure (CPAP) therapy is the first line of treatment for OSA. It’s administered through a face mask worn at night.
Sleep optimization, or, in other words, ‘sleepmaxxing,’ is getting trendy on social media among those prioritizing their sleep routine for some time already. From sleep trackers, mouth taping, nostril ...
Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results